Showing results (1461-1470 of 3,189) with videos related to

Sort By:
Pageof 319
Translational Oncology|November 24, 2024
Prostate cancer risk biomarkers from large cohort and prospective metabolomics studies: A systematic reviewYamilé López-Hernández, Cristina Andres-Lacueva, David S Wishart, et al.
Translational Oncology|November 21, 2024
Advancements in understanding the molecular mechanisms and clinical implications of Von Hippel-Lindau syndrome: A comprehensive reviewYaochun Wang, Jingzhuo Song, Shuxing Zheng, et al.
Translational Oncology|November 29, 2024
FLASH radiotherapy combined with immunotherapy: From biological mechanisms to blockbuster therapeuticsYu Wang, Shu-Nan Qi, Nan Bi, et al.
Translational Oncology|November 28, 2024
Immunogenic clearance combined with PD-1 blockade elicits antitumor effect by promoting the recruitment and expansion of the effector memory-like CD8+T cellSeong A Kim, Seohyun Kim, Yeonsun Hong, et al.
Translational Oncology|December 1, 2024
Predicting response to PD-1 inhibitors in head and neck squamous cell carcinomas using peripheral blood inflammatory markersRuihua Fang, Yi Chen, Bixue Huang, et al.
Translational Oncology|November 30, 2024
Exploring the tumor-suppressive role of miRNA-200c in head and neck squamous cell carcinoma: Potential and mechanisms of exosome-mediated delivery for therapeutic applicationsMohamed S Kishta, Aya Khamis, Hafez Am, et al.
Translational Oncology|November 3, 2024
RPL36A activates ERK pathway and promotes colorectal cancer growthJing Shi, Yebin Yang, Fangci Chen, et al.
Translational Oncology|November 2, 2024
Wnt5a promotes VM formation by modulating the stemness and EMT progression of prostate cancer cellBide Liu, Xun Li, Shuheng Wang, et al.
Translational Oncology|October 15, 2024
First in human intraarterial delivery of tislelizumab for the treatment of pMMR locally advanced rectal cancer: A single-arm, open label, phase II clinical trialWeina Yang, Chengyuan Qian, Jiamin Luo, et al.
Translational Oncology|October 15, 2024
Role of glucose metabolic reprogramming in colorectal cancer progression and drug resistanceRong Qin, Xirui Fan, Yun Huang, et al.
Pageof 319